Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biotest AG Director's Dealing 2016

Mar 31, 2016

66_dirs_2016-03-31_0dbe8fe1-2085-48fb-9395-a175b9c1e58f.html

Director's Dealing

Open in viewer

Opens in your device viewer

News Details

Directors’ Dealings | 31 March 2016 12:26

DGAP-DD: Biotest AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a service of EQS Group AG. The person with duty of notification is solely responsible for the content of this announcement. ————————————————————————— Details of the person subject to the disclosure requirement Company: OGEL GmbH Person performing managerial responsibilities, triggering the disclosure requirement for the legal person Details of the person performing managerial responsibilities Position: Member of an administrative or supervisory body Information about the transaction with duty of notification Description of the financial instrument: Ordinary shares ISIN/WKN of the financial instrument: DE0005227201 Type of transaction: Purchase Date: 30.03.2016 Price: 16.6082 Currency: EUR No. of items: 10000 Total amount traded: 166082 Place: Frankfurt, außerbörslich Information about the company with duty of publication Issuer: Biotest AG Landsteinerstraße 5 63303 Dreieich Germany ISIN: DE0005227235 WKN: 522723 End of Directors’ Dealings Notification (c) DGAP 31.03.2016 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de ID 24953